Galderma
SwitzerlandEntry
2019
Hold
7yr
Status
Active
Who owns Galderma?
Galderma is a Swiss Pharma company, currently owned by Ardian since 2019.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
ArdianArdian Co-Investment Fund V · 2019 · Buyout
3 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected · 1 lender on file
Active
Co-invest · 2 holders · 1 lender · 2019 · present
EQTExited 2026
2019 · 2026(7yr) · EQT VIII · 2018 · Buyout
IPO · to Public market investors
EQT took Galderma public via IPO in 2026 after 7 years.
CIC Private DebtLender
2019 · present(7yr) · CM-CIC Debt Fund 3 · 2019 · Private Debt
ArdianActive
2019 · present(7yr) · Ardian Co-Investment Fund V · 2019 · Buyout
More from Ardian Co-Investment Fund V
Other portfolio companies in the same fund.
France
Sweden
US
FinlandMore PE-backed in Pharma
Comparable pharma deals from other GPs.
SpainQuestions
Who owns Galderma?
Galderma is currently owned by Ardian, through Ardian Co-Investment Fund V, since 2019.
When did Ardian acquire Galderma?
Ardian acquired Galderma in 2019.
Who did Galderma sell to?
EQT sold Galderma to Public market investors in 2026 (IPO).
Who has owned Galderma over time?
Galderma has been through 3 private-equity ownership periods: EQT · via EQT VIII · 2019–2026 · sold to Public market investors · (IPO); Ardian · via Ardian Co-Investment Fund V · since 2019; CIC Private Debt · via CM-CIC Debt Fund 3 · since 2019.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue